274 related articles for article (PubMed ID: 34824362)
1. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
Lee HS; Lee J; Jo JC; Jung SH; Lee JJ; Kim D; Lee S; Song K
Sci Rep; 2021 Nov; 11(1):22907. PubMed ID: 34824362
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
3. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.
Facon T; Dimopoulos MA; Meuleman N; Belch A; Mohty M; Chen WM; Kim K; Zamagni E; Rodriguez-Otero P; Renwick W; Rose C; Tempescul A; Boyle E; Manier S; Attal M; Moreau P; Macro M; Leleu X; Lorraine Chretien M; Ludwig H; Guo S; Sturniolo M; Tinel A; Silvia Monzini M; Costa B; Houck V; Hulin C; Yves Mary J
Leukemia; 2020 Jan; 34(1):224-233. PubMed ID: 31427722
[TBL] [Abstract][Full Text] [Related]
4. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.
Yhim HY; Park Y; Kim JA; Shin HJ; Do YR; Moon JH; Kim MK; Lee WS; Kim DS; Lee MW; Choi YS; Jeong SH; Kim KH; Kim J; Lee CH; Song GY; Yang DH; Kwak JY
Korean J Intern Med; 2024 May; 39(3):501-512. PubMed ID: 38287501
[TBL] [Abstract][Full Text] [Related]
5. Assessment of prevalence and clinical outcome of frailty in an elderly predialysis cohort using simple tools.
Ali H; Abdelaziz T; Abdelaal F; Baharani J
Saudi J Kidney Dis Transpl; 2018; 29(1):63-70. PubMed ID: 29456209
[TBL] [Abstract][Full Text] [Related]
6. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA.
Facon T; Cook G; Usmani SZ; Hulin C; Kumar S; Plesner T; Touzeau C; Bahlis NJ; Basu S; Nahi H; Goldschmidt H; Quach H; Mohty M; Venner CP; Weisel K; Raje N; Hebraud B; Belhadj-Merzoug K; Benboubker L; Decaux O; Manier S; Caillot D; Ukropec J; Pei H; Van Rampelbergh R; Uhlar CM; Kobos R; Zweegman S
Leukemia; 2022 Apr; 36(4):1066-1077. PubMed ID: 34974527
[TBL] [Abstract][Full Text] [Related]
7. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma.
Mian HS; Wildes TM; Fiala MA
JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30547157
[TBL] [Abstract][Full Text] [Related]
8. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
J Geriatr Oncol; 2024 Mar; 15(2):101681. PubMed ID: 38104480
[TBL] [Abstract][Full Text] [Related]
10. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV
Blood; 2015 Mar; 125(13):2068-74. PubMed ID: 25628469
[TBL] [Abstract][Full Text] [Related]
11. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
[TBL] [Abstract][Full Text] [Related]
12. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.
Murillo A; Cronin AM; Laubach JP; Hshieh TT; Tanasijevic AM; Richardson PG; Driver JA; Abel GA
J Geriatr Oncol; 2019 May; 10(3):486-489. PubMed ID: 30472368
[TBL] [Abstract][Full Text] [Related]
13. Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.
Mateos MV; Dimopoulos MA; Cavo M; Suzuki K; Knop S; Doyen C; Lucio P; Nagy Z; Pour L; Grosicki S; Crepaldi A; Liberati AM; Campbell P; Yoon SS; Iosava G; Fujisaki T; Garg M; Iida S; Bladé J; Ukropec J; Pei H; Van Rampelbergh R; Kudva A; Qi M; San-Miguel J
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):785-798. PubMed ID: 34344638
[TBL] [Abstract][Full Text] [Related]
14. Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China.
Zhong YP; Zhang YZ; Liao AJ; Li SX; Tian C; Lu J
Chin Med J (Engl); 2017 Jan; 130(2):130-134. PubMed ID: 28091402
[TBL] [Abstract][Full Text] [Related]
15. Electronic FRAIL score may predict treatment outcomes in older adults with myeloma.
Chan H; Chong YH; Seow MY; Li J; Garg P; Kelly M; Neylon A; McDiarmid B; Tan S; Jackson S
J Geriatr Oncol; 2021 May; 12(4):515-520. PubMed ID: 33046409
[TBL] [Abstract][Full Text] [Related]
16. Prospective cohort study of elderly patients with coronary artery disease: impact of frailty on quality of life and outcome.
Qayyum S; Rossington JA; Chelliah R; John J; Davidson BJ; Oliver RM; Ngaage D; Loubani M; Johnson MJ; Hoye A
Open Heart; 2020 Sep; 7(2):. PubMed ID: 32989014
[TBL] [Abstract][Full Text] [Related]
17. Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study.
Anic K; Flohr F; Schmidt MW; Krajnak S; Schwab R; Schmidt M; Westphalen C; Eichelsbacher C; Ruckes C; Brenner W; Hasenburg A; Battista MJ
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1551-1560. PubMed ID: 35579719
[TBL] [Abstract][Full Text] [Related]
18. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.
Patel BG; Luo S; Wildes TM; Sanfilippo KM
JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955
[TBL] [Abstract][Full Text] [Related]
19. Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
Bringhen S; Pour L; Benjamin R; Grosicki S; Min CK; C de Farias DL; Vorog A; Labotka RJ; Wang B; Cherepanov D; Cain LE; Manne S; Rajkumar SV; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):491-504. PubMed ID: 37149398
[TBL] [Abstract][Full Text] [Related]
20. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
